Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Pepticom, a pioneer in AI-driven peptide-based therapeutics, today announced the successful completion of its Series A1 funding round, securing $6.6 million. Japan Israel High Tech Ventures 2 LP led ...

“Cost is a big issue for them as they want to produce on a large scale,” says Masuya. “Where they might need 50g of protein, they could do the same with 1-2g of peptide at a fraction of the ...

“There is great need to revolutionize the current inefficient drug discovery and development process, reducing time, cost and risk.” Pepticom, a pioneer in AI-driven peptide drug discovery and ...

Experts recommend 5 peptide-based medications for weight loss, such as liraglutide and semaglutide. They require medical ...

This enables rapid turnaround of new peptide designs as well as cost effective scale-up. Crucially it also offers the opportunity to discover previously inaccessible biosuperiors. Zentraxa has to date ...

Future Prospects: The future of the Vietnam peptide therapeutics market is promising. As healthcare needs continue to grow and research in the field of peptide therapeutics advances, the demand for ...

Elected officials are looking to expand access to weight loss drugs like Ozempic and Wegovy for low-income Virginians as part ...